Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Entrada Therapeutics, Inc. (TRDA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $15.6713, valued at
$15.7k
|
|
| 08/04/2023 |
4
| KREHER NERISSA (Chief Medical Officer) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 9,280 shares
@ $15.0876, valued at
$140k
Sold 1,000 shares
@ $16.0117, valued at
$16k
Sold 68 shares
@ $16.82, valued at
$1.1k
Sold 9,464 shares
@ $14.7432, valued at
$139.5k
Sold 6,898 shares
@ $14.1376, valued at
$97.5k
Exercised 10,348 options to buy
@ $2.1, valued at
$21.7k
Exercised 9,464 options to buy
@ $2.1, valued at
$19.9k
Exercised 6,898 options to buy
@ $2.1, valued at
$14.5k
|
|
| 07/12/2023 |
4
| WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 6,116 shares
@ $17.9788, valued at
$110k
Sold 3,884 shares
@ $17.9979, valued at
$69.9k
Exercised 6,116 options to buy
@ $2.1, valued at
$12.8k
Exercised 3,884 options to buy
@ $2.1, valued at
$8.2k
|
|
| 07/12/2023 |
4
| Dowden Nathan J (COO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 3,200 shares
@ $18.0016, valued at
$57.6k
Sold 3,897 shares
@ $18.048, valued at
$70.3k
|
|
| 07/12/2023 |
4
| Sethuraman Natarajan (Chief Scientific Officer) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 3,026 shares
@ $18.002, valued at
$54.5k
Sold 14,852 shares
@ $18.039, valued at
$267.9k
|
|
| 06/30/2023 |
4
| WENTWORTH KORY JAMES (CFO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Exercised 8,790 options to buy
@ $2.1, valued at
$18.5k
|
|
| 06/12/2023 |
4
| PARMAR KUSH (10% Owner) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $14.67, valued at
$234.7k
|
|
| 06/12/2023 |
4
| Thistle Mary (Director) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $14.67, valued at
$234.7k
|
|
| 06/12/2023 |
4
| Crowley John F (Director) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $14.67, valued at
$234.7k
|
|
| 06/12/2023 |
4
| KIM PETER S (Director) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $14.67, valued at
$234.7k
|
|
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Zeiher Bernhardt G (Director) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 32,000 options to buy
@ $14.43, valued at
$461.8k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2023 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $12, valued at
$24k
|
|
| 01/30/2023 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $12.0005, valued at
$24k
|
|
| 01/10/2023 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 2,410 shares
@ $15.0189, valued at
$36.2k
|
|
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 2,795 shares
@ $15.2165, valued at
$42.5k
Sold 288 shares
@ $16.3028, valued at
$4.7k
Sold 3,453 shares
@ $15.0402, valued at
$51.9k
Sold 966 shares
@ $15.824, valued at
$15.3k
Sold 3,085 shares
@ $15.2339, valued at
$47k
|
|
| 09/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2022 |
4
| Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Sold 3,402 shares
@ $15.1162, valued at
$51.4k
Sold 1,023 shares
@ $15.066, valued at
$15.4k
|
|
|
|
|